About PRIA

Pria was founded in 2002 to bring the benefits of  fluorescent clinical diagnostics into point-of-care and consumer markets. Since founding, the company has developed a novel diagnostics platform and built its first product Element.  In addition to Pria´s internal development efforts, the Company has on-going collaborations with top tier universities as well as working as a sub-contractor on DARPA and NIH grant programs.

Pria is currently evaluating partnership and licensing opportunities using its NanoFL platform in diagnostics applications addressing autoimmune diseases, infectious diseases, bioweapons, industrial screening and environmental monitoring. For more information on partnership opportunities, please contact Business Development.

Pria is a privately-held, privately-funded medical device company. For investor information, please contact Investor Relations.